Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index

被引:35
|
作者
Cohen, Ricardo [1 ]
Caravatto, Pedro Paulo
Correa, Jose Luis
Noujaim, Patricia
Petry, Tarissa Zanata
Salles, Joao Eduardo
Schiavon, Carlos Aurelio
机构
[1] Hosp Alemao Oswaldo Cruz, Ctr Surg Treatment Morbid & Metab Disorders, Dept Surg, BR-01411000 Sao Paulo, Brazil
关键词
Bariatric surgery; Glucose metabolism; Insulin sensitivity; GASTRIC BYPASS; WEIGHT-LOSS; INSULIN-RESISTANCE; TYPE-2; OBESITY; GLUCOSE; DIET;
D O I
10.1016/j.soard.2012.01.017
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Bariatric surgery frequently results in the resolution of type 2 diabetes mellitus (T2DM). One of the many factors that could explain such findings is the duodenal exclusion of the alimentary tract. To test this hypothesis, a surgical model that induces glycemic control without significant weight loss would be ideal. In the present study, we evaluated the early metabolic changes that occur in overweight diabetic patients after laparoscopic duodenal-jejunal bypass (DJB) and determined the factors associated with success in T2DM resolution. The setting was a private practice. Methods: A total of 35 patients (20 men and 15 women) were included in the present study. The mean preoperative body mass index was 28.4 +/- 2.9 kg/m(2). DJB was performed in all patients, and the anthropometric data and blood samples were collected at baseline (preoperatively) and 3, 6, 9, and 12 months after surgery. Success was defined when patients reached a glycated hemoglobin level of <7% without diabetic medication. Results: T2DM remission was observed in 14 (40%) of 35 patients. No differences in the homeostasis model assessment insulin resistance index levels and patient weight were observed before and 12 months after DJB surgery. Gender, duration of T2DM, previous use of insulin, preoperative homeostasis model assessment insulin resistance index, and C-peptide levels were not significant predictive factors of success or nonsuccess. The only factor that significantly predicted postoperative positive outcomes was a waist circumference reduction of >= 7% compared with baseline within the first 6 months after surgery. Conclusion: DJB improves glycemic control; however, it does not increase insulin sensitivity in overweight diabetic patients. These changes were observed without significant weight loss. (Surg Obes Relat Dis 2012;8:375-380.) (c) 2012 American Society for Metabolic and Bariatric Surgery. All rights reserved.
引用
收藏
页码:375 / 380
页数:6
相关论文
共 50 条
  • [1] Early Changes in Incretin Secretion After Laparoscopic Duodenal-Jejunal Bypass Surgery in Type 2 Diabetic Patients
    Lee, Hong Chan
    Kim, Mee Kyoung
    Kwon, Hyuk Sang
    Kim, Eungkook
    Song, Ki-Ho
    OBESITY SURGERY, 2010, 20 (11) : 1530 - 1535
  • [2] Surgery for Nonobese Type 2 Diabetic Patients: An Interventional Study with Duodenal-Jejunal Exclusion
    Geloneze, Bruno
    Geloneze, Sylka R.
    Fiori, Carla
    Stabe, Christiane
    Tambascia, Marcos A.
    Chaim, Elinton A.
    Astiarraga, Brenno D.
    Pareja, Jose Carlos
    OBESITY SURGERY, 2009, 19 (08) : 1077 - 1083
  • [3] Exclusion of the Distal Ileum Cannot Reverse the Anti-Diabetic Effects of Duodenal-Jejunal Bypass Surgery
    Chai, Jie
    Zhang, Guangyong
    Liu, Shaozhuang
    Hu, Chunxiao
    Han, Haifeng
    Hu, Sanyuan
    Zhang, Zongli
    OBESITY SURGERY, 2016, 26 (02) : 261 - 268
  • [4] Long-term effects of proximal small bowel exclusion by duodenal-jejunal bypass liner on weight reduction and glycemic control in diabetic patients
    Deutsch, Liat
    Ben Haim, Limor
    Sofer, Yael
    Gluck, Nathan
    Santo, Erwin
    Fishman, Sigal
    SURGERY FOR OBESITY AND RELATED DISEASES, 2018, 14 (10) : 1561 - 1569
  • [5] Moderate Effect of Duodenal-Jejunal Bypass Surgery on Glucose Homeostasis in Patients With Type 2 Diabetes
    Klein, Samuel
    Fabbrini, Elisa
    Patterson, Bruce W.
    Polonsky, Kenneth S.
    Schiavon, Carlos A.
    Correa, Jose L.
    Salles, Joao E.
    Wajchenberg, Bernardo L.
    Cohen, Ricardo
    OBESITY, 2012, 20 (06) : 1266 - 1272
  • [6] Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
    He, Jipei
    Li, Heng
    Dai, Xiaojiang
    Xie, Zhengyong
    Song, Zhigao
    Chen, Xi
    Huang, Hongyan
    Ding, Yunfa
    Qi, Tengfei
    Liu, Qing
    Zhang, Hongbin
    Wu, Liangping
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2024, (212):
  • [7] Trends in BMI, Glycemic Control and Obesity-Associated Comorbidities After Explantation of the Duodenal-Jejunal Bypass Liner (DJBL)
    Riedel, Nina
    Laubner, Katharina
    Lautenbach, Anne
    Schoen, Gerhard
    Schlensak, Matthias
    Stengel, Rainer
    Eberl, Thomas
    Dederichs, Frank
    Aberle, Jens
    Seufert, Jochen
    OBESITY SURGERY, 2018, 28 (08) : 2187 - 2196
  • [8] Sustained weight loss after duodenal-jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m2: A retrospective cohort study
    Boonchaya-Anant, Patchaya
    Bueter, Marco
    Gubler, Christoph
    Gerber, Philipp A.
    CLINICAL OBESITY, 2023, 13 (01)
  • [9] Changes in Glucose Transporters, Gluconeogenesis, and Circadian Clock after Duodenal-Jejunal Bypass Surgery
    Kim, Mikyung
    Son, Young Gil
    Kang, Yu Na
    Ha, Tae Kyung
    Ha, Eunyoung
    OBESITY SURGERY, 2015, 25 (04) : 635 - 641
  • [10] Changes in one-carbon metabolism after duodenal-jejunal bypass surgery
    Jung, Jeeyoun
    Ha, Tae Kyung
    Lee, Jueun
    Lho, Yunmee
    Nam, Miso
    Lee, Doohae
    le Roux, Carel W.
    Ryu, Do Hyun
    Ha, Eunyoung
    Hwang, Geum-Sook
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2016, 310 (08): : E624 - E632